Mission
To advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health.
This mission involves:
- Strategically supporting and conducting basic and clinical research on drug use (including nicotine), its consequences, and the underlying neurobiological, behavioral, and social mechanisms involved.
- Ensuring the effective translation, implementation, and dissemination of scientific research findings to improve the prevention and treatment of substance use disorders and enhance public awareness of addiction as a brain disorder.
NIDA Research helps to
- Understand how the brain works when people use—and don't use—alcohol and drugs such as nicotine, cocaine, opioids, and marijuana.
- Find out what causes people to drink alcohol and use drugs
- Discover new treatments for health problems related to drug and alcohol use
- See how using drugs and alcohol for a long time affects the brain
- Find the best ways to help individuals stop or reduce their alcohol and drug use
Meet our Staff
Lorenzo Leggio, M.D., Ph.D.
Clinical Director, NIDA IRP
Deputy Scientific Director, NIDA IRP
Chief, Translational Addiction Medicine Branch
Chief, Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section
Lisa A. Farinelli, Ph.D., M.B.A., R.N., CCRP, OHCC
Deputy Clinical Director, Office of the Clinical Director
Brenda Curtis, Ph.D., M.S.P.H.
Chief, Technology and Translational Research Unit
David Epstein, Ph.D.
Chief, Real-world Assessment, Prediction, and Treatment Unit
Amy Janes, Ph.D.
Chief, Cognitive and Pharmacological Neuroimaging Unit
Thorsten Kahnt, Ph.D.
Chief, Learning and Decision-Making Unit
Thomas J. Ross, Ph.D.
Director, Neuroimaging Core
Yihong Yang, Ph.D.
Chief, Neuroimaging Research Branch
Chief, Magnetic Resonance Imaging and Spectroscopy Section
Learn more about our research and meet our clinical and research staff here:
Email Newsletter
X
Facebook
LinkedIn
YouTube
Flickr